“Class 10th ID Card” Is Enough For Registration for COVID Vaccine – Officials Said!!!

0
“Class 10th ID Card” Is Enough For Registration for COVID Vaccine
“Class 10th ID Card” Is Enough For Registration for COVID Vaccine

Vaccine For Under 18 (Children) Will Begin From January, 03: Check 15-18 Age Group Registration, Official Statement and Other Details: Omicron a variant of COVID 19 has stepped into India. At this situation, the Prime Minister of India Narendra Modi has announced that the vaccination drive for the children who are in the age group of 15 years to 18 years from January. For this children can register themselves for the same by using their class 10th identity card.

Check Latest Govt Job Notification 2021

Be Ready For 2022 With Vaccination:

Many people have the fear and preparing themselves as precaution as they expected the number of Omicron cases may rise. However, most people at least done their first dose and waiting for the second dose. At this situation the Prime Minister Narendra Modi announced that the children who are in the age group of 15 years to 18 years would start receiving COVID-19 vaccines from 3rd January 2021. And also the healthcare and frontline workers can receive the dose from 10th January as cases of the Omicron.

For the vaccination, the children who are in the mentioned age limit can register themselves by using their school ID card. The chief executive officer of the National Health Authority RS Sharma has stated regarding that “We have added an additional (10th) ID card for registration, the student ID card, because some might not have Aadhaar or other identity cards”.

**To Join Latest Job Update WhatsApp Group**

Why COVAXIN?

According to the trusted news source, the Bharat Biotech’s COVAXIN has been granted approval for restricted use in an emergency situation for the children whose age lies between 12 and 18 years.  After Zydus Healthcare’s ZyCoV-D, COVAXIN is the second vaccine which has been approved for the usage for the child aged 12 years and above. Chairperson of COVID-19 working group of the NTAGI Dr NK Arora has also stated that the COVAXIN has better immune response in children in trials. However, we have to wait to see the success of mass vaccination of India. Stay connected for the useful updates regarding this.

12th Pass Govt Jobs!!!

To Join Whatsapp
Click Here
To Subscribe Youtube Click Here
To Join Telegram Channel
Click Here
Online ClassesClick Here

LEAVE A REPLY

Please enter your comment!
Please enter your name here